WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2026 Issue has been successfully launched on 1 FEBRUARY 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR February 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

  Indexing

  • Google Scholar
  • Index Copernicus
  • SOCOLAR, China
  • Research Bible, Fuchu, Tokyo. JAPAN
  • Cosmos Impact Factor
  • Scientific Indexing Services (SIS)
  • UDLedge Science Citation Index
  • International Impact Factor Services
  • International Society for Research Activity (ISRA) Journal Impact Factor (JIF)
  • Scientific Journal Impact Factor (SJIF)
  • IFSIJ Measure of Journal Quality
  • International Scientific Indexing, UAE (ISI) (Under Process)
  • International Impact Factor Services (IIFS)
  • Web of Science Group (Under Process)
  • Directory of Research Journals Indexing
  • Scholar Article Journal Index (SAJI)
  • International Scientific Indexing ( ISI )
  • Academia
  • Scope Database
  • Research Publication Rating and Indexing
  • Doi-Digital Online Identifier
  • ISSN National Centre
  • Zenodo Indexing
  • International CODEN Service, USA

Abstract

THE CORRELATION OF PERIPHERAL EOSINOPHILIA WITH THE SEVERITY AND EXACERBATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS

*Mohammed Abdul-Ridha Hamed, Hassan Salim Al-Jumaily

ABSTRACT

Background: Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disorder characterized by persistent airflow limitation and diverse inflammatory phenotypes. The eosinophilic phenotype has gained attention because of its potential association with exacerbation risk, disease severity, and corticosteroid responsiveness. Aim: This study evaluated the relationship between peripheral blood eosinophil counts and markers of disease severity, including spirometric indices, GOLD stage, and recent exacerbation frequency, among patients with COPD. Methods: A cross-sectional analytical study was conducted on 100 patients aged ≥40 years with confirmed COPD (post-bronchodilator FEV1/FVC <0.70) attending outpatient clinics at Mirjan Medical City, Babylon, Iraq. Peripheral blood eosinophil counts were measured and patients were categorized into two groups: <300 cells/μL and ≥300 cells/μL. Pulmonary function was assessed using spirometry. Associations between eosinophil levels and FEV1% predicted, GOLD stage, and exacerbations in the preceding six months were analyzed using Spearman’s rank correlation. Results: The median eosinophil count was 247.5 cells/μL. Patients with eosinophil counts ≥300 cells/μL demonstrated significantly lower median FEV1% predicted (48% vs. 75%; p<0.001) and post-bronchodilator FEV1 (55% vs. 79%; p<0.001). Eosinophil counts increased progressively across GOLD stages, from 62.5 cells/μL in stage 1 to 805 cells/μL in stage 4. Significant negative correlations were observed between eosinophil counts and lung function parameters, while positive correlations were identified with GOLD stage (ρ=0.623, p<0.001) and exacerbation frequency (ρ=0.490, p<0.001). Conclusion: Elevated peripheral eosinophil counts are strongly associated with greater airflow limitation, advanced disease severity, and increased exacerbation burden in COPD, supporting their role as an accessible biomarker for high-risk phenotyping.

[Full Text Article] [Download Certificate]